Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03787680
Title Targeting Resistant Prostate Cancer With ATR and PARP Inhibition (TRAP Trial)
Recruitment Active, not recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors University of Michigan Cancer Center
Indications

prostate adenocarcinoma

Therapies

Ceralasertib + Olaparib

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.